# Parenteral Nutrition in the Health-Care Setting: A Comprehensive Review

Hani Raka Karrar, Mahmoud Ismail Nouh, Manal Meqbel Albogami, Ajayeb Ayed Aldosari, Maram Saad Alshalawi, Ghaday Abdulazizi Abdulmajeed, Radhwan Mokhtar Khalifa, Reham Ahmed Hazazi, Abdulaziz Mousa Mahzara

► To cite this version:

Hani Raka Karrar, Mahmoud Ismail Nouh, Manal Meqbel Albogami, Ajayeb Ayed Aldosari, Maram Saad Alshalawi, et al.. Parenteral Nutrition in the Health-Care Setting: A Comprehensive Review. Journal of Pharmaceutical Research International, 2024, 36, pp.104 - 115. 10.9734/jpri/2024/v36i127632. hal-04896492

HAL Id: hal-04896492

https://hal.science/hal-04896492v1

Submitted on 20 Jan 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

# Parenteral Nutrition in the Health-Care Setting: A Comprehensive Review

Hani Raka Karrar a*, Mahmoud Ismail Nouh b,
Manal Meqbel Albogami c, Ajayeb Ayed Aldosari c,
Maram Saad Alshalawi c,
Ghaday Abdulazizi Abdulmajeed c,
Radhwan Mokhtar Khalifa d, Reham Ahmed Hazazi c
and Abdulaziz Mousa Mahzara e

## Authors' contributions

This work was carried out in collaboration among all authors. All authors read and approved the final manuscript.

## Article Information

DOI: https://doi.org/10.9734/jpri/2024/v36i127632

**Open Peer Review History:**
This journal follows the Advanced Open Peer Review policy. Identity of the Reviewers, Editor(s) and additional Reviewers, peer review comments, different versions of the manuscript, comments of the editors, etc are available here: https://www.sdiarticle5.com/review-history/127763

Received: 02/10/2024

Accepted: 05/12/2024

Published: 07/12/2024

## Review Article

<footnote>a Pharmaceutical Care, Faculty of Pharmacy, Dr. Samir Abbas Hospital, Jeddah, Alazhar University, Jeddah, Saudi Arabia.</footnote>

<footnote>b Pharmaceutical Care, Department of Medicine, King Fahad Armed Forces Hospital, Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia.</footnote>

<footnote>c Security Forces Hospital, Riyadh, Saudi Arabia.</footnote>

<footnote>d Jeddah First Health Cluster, King Abdulaziz Hospital, Jeddah, Saudi Arabia.</footnote>

<footnote>e Jazan Health Cluster, Jazan, Saudi Arabia.</footnote>

<footnote>*Corresponding author: E-mail: hanywell2006m@hotmail.com;</footnote>
ABSTRACT

Parenteral Nutrition (PN) is a critical therapeutic technique that delivers necessary nutrients straight into the circulation, bypassing the gastrointestinal system. This strategy is critical for people who are unable to acquire appropriate nourishment through oral or enteral routes owing to a variety of medical issues. PN first appeared in the mid-twentieth century, primarily to help those who were very malnourished or recuperating from significant surgery. As medical understanding of nutrition grew, so did the complexity and customization of PN formulations, allowing for personalized nutritional support depending on metabolic demands. The indications for PN are diverse, including gastrointestinal diseases, cancer therapies, severe illnesses, neurological issues, and pediatric demands. Patients suffering with Crohn's illness, short gut syndrome, and severe malnutrition caused by cancer therapies frequently rely on PN to maintain their nutritional status. Furthermore, critically sick patients in intensive care settings typically encounter elevated metabolic demands, needing efficient nutritional therapies that oral feeding cannot deliver. While PN has considerable advantages, such as increased recovery, malnutrition prevention, and quality of life, it is not without hazards. Infections, metabolic abnormalities, and liver dysfunction are all possible complications, emphasizing the importance of thorough monitoring and following best practices in PN administration. A multidisciplinary approach including healthcare specialists from several professions is required to achieve the best outcomes for patients seeking PN. Looking ahead, technological developments, personalized dietary techniques, and artificial intelligence integration promise to improve the safety and efficacy of PN. Continuous research and innovation are required to solve current difficulties and enhance the overall quality of care for patients requiring parenteral feeding. As the healthcare environment shifts, PN will remain an important component of nutritional support, requiring continuing attention and development in clinical practice.

Keywords: Parenteral nutrition; health-care setting; comprehensive review.

1. INTRODUCTION

Parenteral nutrition (PN) is a vital therapeutic procedure that delivers important nutrients straight into the bloodstream, circumventing the gastrointestinal system. This nutritional support strategy is especially beneficial for people unable to ingest food orally or absorb nutrients effectively due to diverse medical issues. As healthcare progresses, the job of the PN has evolved, becoming essential in patient management across many clinical environments (Pybus and Puntis, 2021). PN was historically introduced in the mid-20th century to assist patients with severe malnutrition or those having significant surgical procedures. Initial formulations were basic and mostly comprised dextrose and electrolytes. As our comprehension of nutritional biochemistry has advanced, the complexity and effectiveness of parenteral feeding formulas have also increased. Currently, parenteral nutrition can be customized to address the distinct metabolic requirements of individual patients, integrating a balanced composition of carbohydrates, proteins, fats, vitamins, and minerals. The indications for PN are extensive and cover several medical disorders. Individuals with gastrointestinal diseases, including Crohn's disease, short bowel

syndrome, and acute pancreatitis, frequently necessitate parenteral nutrition due to their incapacity to assimilate nutrients via the digestive system. Moreover, persons receiving cancer treatment may have considerable weight loss and malnutrition as a consequence of chemotherapy side effects or the disease itself. In the intensive care unit (ICU), critically ill patients frequently possess increased nutritional demands yet may be unable of tolerating oral or enteral feeding, rendering PN an essential alternative for maintaining their energy and nutrient needs. The advantages of PN surpass basic nutritional assistance. Proper dietary intake can markedly accelerate recovery times, diminish problems, and boost overall patient outcomes. In surgical patients, adequate nutritional care can result in shorter hospital stays and decreased postoperative complication rates. Moreover, for patients with chronic conditions or those undergoing extended recovery, parenteral nutrition can supply essential nutrients to preserve muscle mass and immunological function, so enhancing overall quality of life. Notwithstanding its benefits, the administration of parenteral nutrition entails several hazards. Complications may occur, such as infections associated with central venous catheters, metabolic imbalances, and hepatic dysfunction.
Consequently, vigilant oversight and compliance with established processes are crucial for mitigating these risks. Healthcare providers must possess comprehensive training in the complexities of PN management to guarantee excellent patient results (Boullata et al., 2022). PN constitutes a significant advancement in nutritional assistance in healthcare. Its capacity to deliver customized, effective nutritional therapy to patients with intricate requirements highlights its significance. As healthcare progresses, continuous research and innovation in parenteral nutrition formulations, delivery methods, and patient management strategies will be essential for improving the quality and safety of this critical therapeutic intervention (Luo et al., 2022).

## 2. INDICATIONS FOR PARENTERAL NUTRITION

PN is warranted in numerous clinical situations where patients are unable to fulfill their nutritional requirements by oral or enteral methods. The determination to commence parenteral feeding is frequently contingent upon the patient's medical state, nutritional status, and the expected period of necessary nutritional assistance. Presented below are essential indications for PN

### 2.1 Gastrointestinal Disorders

Individuals with gastrointestinal issues often necessitate parenteral nutrition due to their impaired nutrient absorption. Conditions that frequently require parenteral nutrition include Short Bowel Syndrome, This disorder results from surgical resections or congenital defects that diminish the functional length of the intestine, hindering nutrient absorption. Patients frequently necessitate parenteral feeding to fulfill their nutritional requirements (Hellerman, 2020). Severe Inflammatory Bowel Disease, Disorders such as Crohn's disease and ulcerative colitis may result in considerable malabsorption and consequences, including strictures or fistulas. Parenteral nutrition may be crucial during exacerbations or when patients are unable to endure enteral feeding (Lopez-Delgado et al., 2023). Bowel Obstruction, Mechanical or functional bowel blockages can impede the transit of food and the absorption of nutrients. In such instances, PN offers a method to supply vital nutrients while the fundamental problem is resolved (Bozzetti, 2019).

### 2.2 Cancer and Cancer Treatment

Cancer patients may have malnutrition due to the disease itself or as an adverse effect of treatments such as chemotherapy and radiation. PN may be indicated for cancer cachexia, this illness entails involuntary weight reduction and muscle atrophy, which can profoundly affect therapy results. Parenteral nutrition can enhance nutritional status and elevate quality of life. Gastrointestinal Malignancies, Neoplasms in the gastrointestinal system may impede the transit of meals, requiring parenteral feeding to sustain nutritional intake. Chemotherapy-Induced Nausea and Vomiting, Chemotherapy may induce significant nausea and vomiting, complicating patients' ability to maintain sufficient oral nutrition (Amano et al., 2021, McGrath, 2019).

### 2.3 Critical Illness

Patients in critical care environments frequently necessitate parenteral nutrition due to increased metabolic requirements and insufficient oral intake. In this sense, indications encompass Significant Trauma or Burns, Trauma patients exhibit elevated energy demands and may have impaired gastrointestinal function. PN can facilitate recovery by addressing these nutritional requirements. Sepsis: In individuals with sepsis, the metabolic response is markedly modified, and enteral nutrition may be poorly tolerated. PN can deliver vital nutrients while reducing gastrointestinal strain. Postoperative Patients, Individuals recuperating after significant surgeries, particularly those affecting the gastrointestinal tract, may necessitate parenteral nutrition if they cannot accept oral intake during the early recovery period (Compher et al., 2022, Al-Dorzi and Arabi, 2021).

### 2.4 Neurological Conditions

Certain neurological disorders may hinder swallowing and elevate the risk of aspiration, rendering parenteral nutrition an appropriate alternative for Stroke, Individuals who have experienced a stroke may have dysphagia, hindering sufficient oral intake. Neuromuscular Disorders, Conditions like amyotrophic lateral sclerosis (ALS) and multiple sclerosis may impair eating capabilities, requiring parenteral nutrition for nutritional support (Jersak et al., 2022).
## 2.5 Malnutrition and Failure to Thrive

Patients with chronic conditions, such as chronic obstructive pulmonary disease (COPD) or heart failure, may experience malnutrition resulting from elevated energy expenditure and diminished intake. Parenteral nutrition can aid in the restoration of nutritional status in patients at risk of currently experiencing malnutrition (Smith et al., 2024).

## 2.6 Pediatric Indications

In pediatrics, parenteral nutrition is essential for newborns and children with problems that hinder their capacity to feed enterally, including preterm babies, critically ill babies, babies who need surgery, congenital defects, serious burns, or metabolic disorders. Ensuring sufficient nutrition in this demographic is essential for growth and development (Johnson et al., 2022).

# 3. BENEFITS OF PARENTERAL NUTRITION

Parenteral nutrition provides several advantages, rendering it a crucial aspect of medical treatment for individuals with particular nutritional requirements. The following are few key advantages.

### 3.1 Comprehensive Nutritional Support

PN offers a comprehensive nutritional profile tailored to the specific requirements of patients. It can be engineered to provide exact quantities of macronutrients (carbohydrates, proteins, and fats) and micronutrients (vitamins and minerals), guaranteeing that patients obtain all necessary nutrients, irrespective of their capacity to consume food orally (Mulazzani et al., 2021).

### 3.2 Prevention of Malnutrition

One of the principal advantages of PN is its capacity to avert malnutrition in individuals who cannot sustain sufficient nutritional intake. Parenteral nutrition delivers vital nutrients straight into the bloodstream, thereby preventing consequences related to malnutrition, including muscular atrophy, immunological impairment, and protracted wound healing (Murphy, 1987).

### 3.3 Enhanced Recovery

In critically ill patients or those convalescing from surgery, sufficient nutritional care can markedly

improve recovery. Research indicates that patients undergoing parenteral nutrition frequently have abbreviated hospitalizations, less postoperative complications, and enhanced overall results (Durán-Poveda et al., 2022).

## 3.4 Flexibility in Administration

Parenteral nutrition can be provided in diverse environments, including hospitals, outpatient clinics, and home settings. This adaptability facilitates uninterrupted care and enables the transition of patients to home parenteral nutrition (HPN) when suitable, thereby enhancing their quality of life (Kumpf et al., 2024).

## 3.5 Support for Metabolic Demands

Critical illness and postoperative recuperation may result in heightened metabolic requirements. Parenteral nutrition can supply the requisite calories and nutrients to address these increased demands, aiding in the stabilization of the patient's state and facilitating recovery (Ley et al., 2023).

## 3.6 Improvement in Quality of Life

For individuals unable to consume food due to illness, parenteral nutrition can markedly enhance quality of life by mitigating symptoms of malnutrition. Patients frequently express enhanced strength and increased ability to participate in daily activities when provided with sufficient nutritional support by PN. For those patients on long term PN with palliative care can report improved quality of life (Monczka et al., 2024).

## 3.7 Safe Nutritional Option

When administered correctly, parenteral feeding provides a secure means of delivering nourishment. Improvements in formulation, catheter technology, and monitoring procedures have diminished the dangers linked to parenteral nutrition, such as infections and metabolic problems (Haiden and Haschke, 2023).

## 3.8 Multidisciplinary Approach

The provision of parenteral nutrition necessitates a multidisciplinary team comprising physicians, nutritionists, pharmacists, and nurses. This collaborative method guarantees that patients have thorough treatment customized to their own nutritional and medical requirements. Parenteral
nutrition is a crucial resource in healthcare, indicated for various medical problems that hinder nutritional intake or absorption. Its capacity to deliver extensive nutritional support, avert malnutrition, and facilitate recovery highlights its essential function in patient treatment. Although PN entails certain dangers, diligent monitoring and compliance with best practices can enhance its advantages, rendering it an essential element of contemporary medical care. As healthcare progresses, continuous research and innovation in parenteral nutrition will augment its efficacy and safety, guaranteeing that patients have optimal nutritional support customized to their requirements (Baron et al., 2020, El-Chammas and Sood, 2018).

## 4. RISKS AND COMPLICATIONS

PN entails several risks and consequences that healthcare providers must evaluate. Comprehending these potential difficulties is essential for guaranteeing the safe and successful administration of parenteral nutrition (Wang et al., 2023).

### 4.1 Infection

One of the most critical dangers linked to PN is infection, especially catheter-related bloodstream infections (CRBSIs). The utilization of central venous catheters (CVCs) for PN administration establishes a direct conduit for germs to infiltrate the bloodstream. Factors that elevate the risk of infection comprise Extended catheter utilization and prolonged catheter durations that increase the risk of infection. Inadequate aseptic technique, Insufficient sterile protocols during catheter insertion or maintenance may result in contamination. Immunocompromised individuals or those with numerous comorbidities face an elevated risk of infections. These infections may result in serious consequences, such as sepsis, which can adversely affect patient outcomes and extend hospitalizations (Lafuente et al., 2023).

### 4.2 Metabolic Complications

Metabolic abnormalities frequently arise in individuals undergoing parenteral nutrition and may result from multiple factors Hyperglycemia, Excessive glucose administration may result in increased blood sugar levels, especially in individuals with diabetes. This is exacerbated by stress-induced insulin resistance frequently observed in critically ill individuals. Electrolyte imbalances, Sudden alterations in fluid and

electrolyte composition may result in conditions such as hypokalemia, hyperkalemia, or hypernatremia. Meticulous oversight and modification of PN formulations are essential to avert severe complications. Refeeding syndrome, This potentially lethal illness may arise with the reinitiation of feeding in malnourished patients, resulting in fast alterations in electrolytes and fluids. It is marked by significant hypophosphatemia, hypokalemia, and nutrient deficits (Adorno et al., 2023, Cioffi et al., 2021).

### 4.3 Liver Complications

Extended PN may result in hepatic impairment, a condition referred to as intestinal failure-associated liver disease (IFALD). This is defined by Cholestasis, Impaired bile flow results in bile buildup inside the liver and increased liver enzyme levels. Steatosis, Excessive fat accumulation in the liver may occur due to elevated lipid consumption in the absence of sufficient enteral nutrition. Regular assessment of liver function tests is crucial, and modifications to the PN regimen may be required to alleviate these risks (Lee et al., 2021, Beath and Kelly, 2016).

### 4.4 Gastrointestinal Atrophy

Although parenteral nutrition circumvents the gastrointestinal tract, extended usage may result in gastrointestinal atrophy. The absence of enteral stimulation may diminish gut motility and mucosal integrity, hindering the reestablishment of enteral feeding. This occurrence may potentially elevate the risk of infections and complicate subsequent dietary management (Jain et al., 2016).

### 4.5 Thrombosis

Utilizing central venous access for parenteral nutrition presents a risk of thrombosis. Catheter-associated thrombosis may arise from mechanical causes, such as catheter misplacement or artery wall irritation, as well as biochemical ones linked to parenteral nutrition composition. This may result in problems including compromised blood circulation and heightened susceptibility to infection (Zaccone et al., 2023).

### 4.6 Psychosocial Impact

Patients necessitating parenteral nourishment, especially those undergoing prolonged home
parenteral nutrition, may encounter psychological and social difficulties. Reliance on PN may result in feelings of loneliness, anxiety, and sadness stemming from food limitations and lifestyle alterations. Supportive treatment and counseling are crucial for addressing these psychosocial dimensions. Parenteral nutrition is an essential method for addressing patients' individual dietary requirements; however, it is imperative to recognize the potential dangers and difficulties involved. Healthcare practitioners must actively monitor potential concerns such as infection, metabolic changes, liver dysfunction, gastrointestinal atrophy, thrombosis, and psychosocial consequences. By employing optimal practices in PN treatment, including as judicious patient selection, rigorous aseptic methods, and consistent monitoring, healthcare providers can mitigate these risks and improve patient outcomes. Continuous education and training for healthcare personnel are crucial to guarantee the safe and effective application of parenteral nutrition in clinical settings (Winkler and Tappenden, 2023).

## 5. CONTRAINDICATIONS

PN is generally contraindicated in the following conditions, Infants with less than 8 cm of the small bowel. Irreversibly decerebrate patients. Patients with critical cardiovascular instability or metabolic instabilities such instabilities require correction before administering intravenous nutrition. When gastrointestinal feeding is possible. When the nutritional status is good, only short term PN is needed. The lack of a therapeutic goal, as PN should not be used to prolong life when death is unescapable (Uthaya, 2021).

## 6. BEST PRACTICES IN PARENTERAL NUTRITION

Compliance with best practices in parenteral nutrition is crucial for safeguarding patient safety, enhancing nutritional results, and reducing problems. This article delineates essential best practices for the proficient management of parenteral feeding (Uthaya, 2021).

### 6.1 Comprehensive Patient Assessment

A comprehensive evaluation of the patient is essential prior to commencing PN. This evaluation must encompass. Nutritional Status, Assess the patient's present nutritional consumption, weight trajectory, and indicators of

malnutrition. Instruments like the Subjective Global Assessment (SGA) or the Malnutrition Universal Screening Tool (MUST) can facilitate this assessment. Medical History, Examine the patient's medical history, encompassing any underlying gastrointestinal issues, chronic illnesses, or recent procedures that could affect nutritional absorption or metabolism. Metabolic Requirements, Assess the patient's caloric and protein requirements considering variables such as age, weight, sex, activity level, and clinical status. The Harris-Benedict equation and the Mifflin-St Jeor equation are valuable for evaluating energy requirements (Malone, 2022, Pavlidou et al., 2023).

### 6.2 Individualized PN Formulation

Customizing the PN formulation to address the patient's particular requirements is essential. This encompasses macronutrient Composition, Establishing the optimal ratio of carbohydrates, proteins, and lipids. Carbohydrates should generally comprise 50-60% of total caloric intake, proteins 15-20%, and fats 25-30%. Nonetheless, these ratios may fluctuate according to individual needs and clinical circumstances. Micronutrient Supplementation incorporates vital vitamins and minerals to avert deficits. The quantities and varieties of micronutrients must be customized to the patient's need, including any preexisting conditions and laboratory findings. Electrolyte Management: Assess and modify electrolyte concentrations by the patient's clinical condition and test findings. The amounts of sodium, potassium, magnesium, and phosphate must be meticulously regulated to prevent consequences, including heart problems or refeeding syndrome (Mutalib et al., 2015).

### 6.3 Aseptic Technique

Infection is a major concern linked to PN. Consequently, rigorous compliance with aseptic methods is imperative, Central Venous Catheter Management: Guarantee appropriate insertion and upkeep of CVCs. Utilize sterile instruments and comply with protocols for sanitizing the insertion site and managing the catheter. Preparation of PN Solutions: PN solutions must be made in a sterile environment, ideally within a sterile compounding pharmacy adhering to international guidelines such as United States Pharmacopeia (USP 797) requirements. Employ aseptic practices to avoid contamination throughout the mixing and administration procedures. Routine Site Surveillance, Observe
the catheter insertion site for indications of infection, including erythema, edema, or exudate. Perform routine evaluations to rapidly identify and mitigate potential issues (Mutalib et al., 2015, Cogle et al., 2024).

## 6.4 Monitoring and Adjustments

Continuous monitoring of patients undergoing parenteral nutrition is essential for guaranteeing safety and efficacy. Laboratory Monitoring: Consistently assess laboratory parameters, encompassing electrolytes, hepatic function tests, and blood glucose levels. These assessments facilitate the early detection of metabolic problems and enable prompt modifications to the PN protocol. Clinical Monitoring, Evaluate the patient's clinical condition daily, encompassing vital signs, fluctuations in weight, and indications of fluid excess or dehydration. Modify PN formulations according to the patient's changing requirements and treatment responses. Reevaluation of Nutritional Requirements, Regularly reevaluate the patient's nutritional needs, especially following substantial alterations in clinical condition, such as surgical procedures, infections, or fluctuations in body weight (Kum et al., 2023).

## 6.5 Transitioning to Enteral or Oral Nutrition

Whenever feasible, prioritizing the transfer of patients from parenteral nutrition to enteral or oral nutrition is essential for enhancing gut health. Gradual Transition, commence enteral feeding incrementally while maintaining parenteral nutrition to guarantee sufficient nutrient provision. Closely observe tolerance for indications of gastrointestinal malfunction. Evaluate Gastrointestinal Function: Assess the patient's gut function before transferring. Administer enteral nourishment to promote gastrointestinal function and avert atrophy if the gut is operational. Nutritional Counseling: Provide dietary guidance to inform patients and caregivers about the transition to oral or enteral feeding. This encompasses directives on meal planning, dietary selections, and surveillance for negative consequences (Greene et al., 2023, Avitzur and Courtney-Martin, 2016).

## 6.6 Education and Training

Education is essential for proficient PN management. This encompasses Staff Training, guaranteeing that all healthcare providers

engaged in PN management have thorough training on optimal practices, encompassing aseptic procedures, monitoring protocols, and the significance of personalized care. Patient and Caregiver Education, instruct patients and their families regarding PN, encompassing its objectives, potential hazards, and the significance of compliance with prescribed protocols. Supply details regarding catheter maintenance and indicators of problems (Mundi et al., 2023).

## 6.7 Multidisciplinary Team Approach

A multidisciplinary team is crucial for the effective execution of PN. Interdisciplinary Collaboration, Engage dietitians, pharmacists, nurses, and physicians in the planning and management of PN. This cooperative method guarantees thorough treatment and facilitates the exchange of expertise. Routine Team Meetings: Conduct routine meetings to evaluate patient progress, address issues, and implement requisite modifications to PN regimens. This promotes communication and improves patient outcomes (Rothkopf et al., 2022).

## 6.8 Quality Improvement Measures

Implementing quality improvement methods can improve the safety and efficacy of PN. Defined Standardized Protocols and formulate and comply with defined protocols for parenteral nutrition administration, monitoring, and troubleshooting. This guarantees uniformity and reduces variability in care. Auditing and Feedback: Conduct regular audits of PN processes and outcomes to pinpoint areas that need enhancement. Deliver feedback to the healthcare team and modify practices according to the findings. Research and Innovation, Remain updated on the most recent research and advancements in parenteral nutrition formulas, administration methodologies, and patient management approaches. Modify practices according to new evidence to enhance patient outcomes. Best practices in parenteral nutrition are essential for safeguarding patient safety, enhancing nutritional results, and reducing problems. Through thorough evaluations, personalized PN formulations, strict adherence to aseptic protocols, and continuous monitoring, healthcare professionals can markedly improve the efficacy of PN. A multidisciplinary approach, along with ongoing education and quality enhancement initiatives, significantly aids in the effective management of
patients necessitating parenteral nourishment. As healthcare evolves, remaining informed about best practices will be crucial for providing high-quality treatment to this at-risk patient demographic (Köglmeier et al., 2022, Chen et al., 2022, Rougier et al., 2021).

# 7. FUTURE DIRECTIONS OF PARENTERAL NUTRITION

With the progression of medical knowledge, the future of PN appears promising for improved safety, efficacy, and patient outcomes. Key areas for future development in parenteral nutrition are technological advancements, individualized nutrition, artificial intelligence integration, and research activities (Katoue, 2018).

## 7.1 Technological Advancements

Technological innovation is set to revolutionize the domain of PN. A significant area of progress is the advancement of intelligent infusion systems. These systems can oversee and modify nutrient distribution in real time, minimizing the likelihood of human error and enhancing nutrient administration. For example, intelligent pumps could autonomously modify flow rates by continuous glucose monitoring, guaranteeing that patients obtain the appropriate glucose dosage while preventing hyperglycemia. Moreover, the implementation of sophisticated compounding technologies, including automated compounding systems, can improve the precision and sterility of parenteral nutrition formulations. These technologies reduce the likelihood of contamination and human mistakes, enabling pharmacists to formulate intricate nutrient solutions with enhanced efficiency (Curtis, 2018).

## 7.2 Individualized Nutrition

The future of customized nutrition is progressing towards increasingly individualized nutrition strategies. Advancements in genetics and metabolomics allow healthcare professionals to customize nutritional support according to unique patient profiles, encompassing genetic predispositions and metabolic reactions. Through the analysis of a patient's genetic composition, healthcare personnel can more accurately anticipate their responses to nutrients, resulting in more effective and personalized parenteral nutrition formulas. Furthermore, the principle of precision nutrition, which takes into account variables such as age, gender, preexisting health issues, and lifestyle, will be pivotal in

personalized nutrition. This customized strategy can augment nutritional absorption and utilization, hence enhancing patient outcomes and quality of life (Cheon et al., 2023, Iresjö et al., 2024).

## 7.3 Integration of Artificial Intelligence for Artificial Intelligence (AI)

possesses the capacity to transform PN management. Healthcare providers can utilize machine learning algorithms to evaluate extensive patient data, thereby identifying patterns and predicting dietary requirements with more precision. Artificial intelligence can facilitate Nutritional Requirement Forecasting: Predictive analytics can ascertain a patient's caloric and protein necessities depending on their clinical status, recovery path, and metabolic alterations. AI facilitates real-time monitoring of patient reactions to parenteral nutrition, enabling prompt modifications to nutritional formulations based on laboratory findings and clinical indicators. Risk Assessment: AI can enhance the early detection of patients at elevated risk for consequences, including infections or metabolic abnormalities, thereby facilitating prompt therapies. Ongoing research is crucial for the progression of the PN domain. Future research should concentrate on Long Term Outcomes, Investigating the long-term impact of PN on diverse patient populations, including individuals with chronic conditions and cancer, will enhance best practices and standards. - Innovative Formulations: Investigating novel formulations that include immune-modulating nutrients, such as omega-3 fatty acids or certain amino acids, may augment the therapeutic efficacy of PN. Cost-Effectiveness Evaluating the economic ramifications of diverse PN techniques will assist healthcare systems in optimizing resource allocation and enhancing patient access to essential nutritional support (Limketkai et al., 2021, Pradelli et al., 2021).

## 7.4 Addressing Ethical and Accessibility Issues

As PN progresses, it is imperative to confront ethical problems and provide fair access to nutritional support. Future endeavors ought to concentrate on Ethical criteria, establishing explicit ethical criteria for the application of PN, especially in at-risk populations such as children and the elderly, will facilitate equitable distribution of PN benefits. Access to Care, Initiatives must be undertaken to enhance access to PN, especially in marginalized areas.
This may encompass telehealth consultations, community education, and assistance for home parenteral nutrition programs (Bower et al., 2023 Euteneuer, 2022).

## 7.5 Focus on HPN

Is an essential therapeutic intervention for patients necessitating prolonged nutritional care who are unable to achieve sufficient nutrition by oral or enteral methods. This therapy enables patients to obtain essential nutrients at home, improving their quality of life and fostering increased independence. HPN is commonly employed by persons suffering with chronic gastrointestinal disorders, including short bowel syndrome, inflammatory bowel disease, or severe malnutrition resulting from cancer. The administration of HPN entails the utilization of a central venous catheter for the direct infusion of a tailored nutritional solution into the bloodstream. This solution comprises vital macronutrients carbohydrates, proteins, and fats alongside vitamins and minerals customized to the individual requirements of each patient. Effective HPN necessitates meticulous oversight and administration to avert problems, including infections and metabolic disturbances. Patient education and support are essential elements, guaranteeing that individuals and caregivers are adequately informed about the administration procedure, potential dangers, and the significance of regular follow-up with healthcare practitioners. HPN can markedly boost patient outcomes and improve daily living. The future of parenteral nutrition is promising, with several chances for improvement that might elevate patient care and outcomes. As technology advances, the incorporation of intelligent systems, tailored nutrition, and artificial intelligence will markedly enhance the safety and effectiveness of parenteral feeding. Continuous education and research will be essential in enhancing best practices and tackling the ethical implications associated with PN. By concentrating on these prospective avenues, healthcare personnel may guarantee that parenteral nutrition continues to be an essential and efficacious element of contemporary medical care while enhancing the quality of life for patients reliant on this life-sustaining treatment (Euteneuer, 2022, Koenen et al., 2019).

## 8. CONCLUSION

In conclusion, parenteral nutrition is a fundamental aspect of contemporary healthcare, requiring continuous innovation and cooperation

among healthcare providers to achieve best patient results. Continuous research and innovation are required to solve current difficulties and enhance the overall quality of care for patients requiring parenteral feeding. As the healthcare environment shifts, PN will remain an important component of nutritional support, requiring continuing attention and development in clinical practice.

## DISCLAIMER (ARTIFICIAL INTELLIGENCE)

Author(s) hereby declare that NO generative AI technologies such as Large Language Models (ChatGPT, COPILOT, etc) and text-to-image generators have been used during writing or editing of this manuscript.

## CONSENT AND ETHICAL APPROVAL

It is not applicable.

## COMPETING INTERESTS

Authors have declared that no competing interests exist.

## REFERENCES

Adorno, A., Ghio, M., Simpson, J. T., Rogers, N., & Guidry, C. (2023). Metabolic impact of high lipid low dextrose parenteral nutrition. *Clinical Nutrition ESPEN*, *57*, 213-218.
https://doi.org/10.1016/j.clnesp.2023.06.005

Al-Dorzi, H. M., & Arabi, Y. M. (2021). Nutrition support for critically ill patients. *JPEN Journal of Parenteral and Enteral Nutrition*, *45*(S2), 47-59.
https://doi.org/10.1002/jpen.1980

Amano, K., Maeda, I., Ishiki, H., Miura, T., Hatano, Y., Tsukuura, H., et al. (2021). Effects of enteral nutrition and parenteral nutrition on survival in patients with advanced cancer cachexia: Analysis of a multicenter prospective cohort study. *Clinical Nutrition* (Edinburgh, Scotland), *40*(3), 1168-1175.
https://doi.org/10.1016/j.clnu.2020.06.028

Avitzur, Y., & Courtney-Martin, G. (2016). Enteral approaches in malabsorption. *Best Practice & Research Clinical Gastroenterology*, *30*(2), 295-307.

Baron, T. H., DiMaio, C. J., Wang, A. Y., & Morgan, K. A. (2020). American Gastroenterological Association Clinical Practice Update: Management of
pancreatic necrosis. *Gastroenterology*, **158**(1), 67-75.e1. https://doi.org/10.1053/j.gastro.2019.08.028

Beath, S. V., & Kelly, D. A. (2016). Total parenteral nutrition-induced cholestasis: Prevention and management. *Clinics in Liver Disease*, **20**(1), 159-176.

Boullata, J. I., Mirtallo, J. M., Sacks, G. S., Salman, G., Gura, K., Canada, T., et al. (2022). Parenteral nutrition compatibility and stability: A comprehensive review. *JPEN Journal of Parenteral and Enteral Nutrition*, **46**(2), 273-299. https://doi.org/10.1002/jpen.2201

Bower, K. L., Shilling, D. M., Bonnes, S. L., Shah, A., Lawson, C. M., Collier, B. R., et al. (2023). Ethical implications of nutrition therapy at the end of life. *Current Gastroenterology Reports*, **25**(3), 69-74.

Bozzetti, F. (2019). The role of parenteral nutrition in patients with malignant bowel obstruction. *Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer*, **27**(12), 4393-4399.
https://doi.org/10.1007/s00520-019-04846-6

Chen, C., Zhu, D., Zhao, Z., & Ye, X. (2022). Quality of life assessment instruments in adult patients receiving home parenteral and enteral nutrition: A scoping review. *Nutrition in Clinical Practice*, **37**(4), 811-824.

Cheon, S., Oh, S. H., Kim, J. T., Choi, H. G., Park, H., & Chung, J. E. (2023). Nutrition therapy by nutrition support team: A comparison of multi-chamber bag and customized parenteral nutrition in hospitalized patients. *Nutrients*, **15** (11).

Cioffi, I., Ponzo, V., Pellegrini, M., Evangelista, A., Bioletto, F., Ciccone, G., et al. (2021). The incidence of the refeeding syndrome: A systematic review and meta-analyses of literature. *Clinical Nutrition* (*Edinburgh, Scotland*), **40**(6), 3688-3701. https://doi.org/10.1016/j.clnu.2020.11.009

Cogle, S. V., Ayers, P., Berger, M. M., Berlana, D., Wischmeyer, P. E., Ybarra, J., et al. (2024). Parenteral nutrition in the hospital setting/short-term parenteral nutrition. *American Journal of Health-System Pharmacy*, **81**(Supplement_3), S102-S111.

Compher, C., Bingham, A. L., McCall, M., Patel, J., Rice, T. W., Braunschweig, C., et al. (2022). Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition. *JPEN Journal of Parenteral and Enteral Nutrition*, **46**(1), 12-41. https://doi.org/10.1002/jpen.2125

Curtis, C. (2018). Technology in parenteral nutrition compounding. *Nutrition in Clinical Practice*, **33**(6), 796-802.

Durán-Poveda, M., Bonavina, L., Reith, B., Caruso, R., Klek, S., & Senkal, M. (2022). Nutrition practices with a focus on parenteral nutrition in the context of enhanced recovery programs: An exploratory survey of gastrointestinal surgeons. *Clinical Nutrition ESPEN*, **50**, 138-147. https://doi.org/10.1016/j.clnesp.2022.07.008

El-Chammas, K., & Sood, M. R. (2018). Chronic intestinal pseudo-obstruction. *Clinics in Colon and Rectal Surgery*, **31**(2), 99-107. https://doi.org/10.1055/s-0038-1667669

Greene, Z., O'Donnell, C. P., & Walshe, M. (2023). Oral stimulation for promoting oral feeding in preterm infants. *The Cochrane Database of Systematic Reviews*, **2023**(6), Cd009720.

Haiden, N., & Haschke, F. (2023). Early nutrition must be safe and should have positive impacts on long-term health. *Nutrients*, **15**(12). https://doi.org/10.3390/nu15122793

Hellerman Itzhaki, M., & Singer, P. (2020). Advances in medical nutrition therapy: Parenteral nutrition. *Nutrients*, **12**(3). https://doi.org/10.3390/nu12030729

Iresjö, B. M., Smedh, U., Engström, C., Persson, J., Mårtensson, C., & Lundholm, K. (2024). A randomized translational study on protein- and glucose metabolism in skeletal muscles evaluated by geno-ontology, following preoperative oral carbohydrate loading compared to overnight peripheral parenteral nutrition (PPN) before major cancer surgery. *Journal of Translational Medicine*, **22**(1), 675.

Jain, A. K., Wen, J. X., Blomenkamp, K. S., Arora, S., Blaufuss, T. A., Rodrigues, J., et al. (2016). Oleanolic acid improves gut atrophy induced by parenteral nutrition. *JPEN Journal of Parenteral and Enteral Nutrition*, **40**(1), 67-72.
Jersak, T., Kim, S. S., Noritz, G., Testa, M., & Humphrey, L. (2022). Defining persistent total parenteral nutrition use in patients with neurologic impairment. *Journal of Palliative Medicine, 25*(4), 577-583.
https://doi.org/10.1089/jpm.2021.0576

Johnson, M. J., Lapillonne, A., Bronsky, J., Domellof, M., Embleton, N., Iacobelli, S., et al. (2022). Research priorities in pediatric parenteral nutrition: A consensus and perspective from ESPGHAN/ESPEN/ESPR/CSPEN. *Pediatric Research, 92*(1), 61-70. https://doi.org/10.1038/s41390-021-01856-1

K. P. F., Euteneuer, J. C., & Brunelli, L. (2022). Ethical considerations for equitable access to genomic sequencing for critically ill neonates in the United States. *International Journal of Neonatal Screening, 8*(1).

Katoue, M. G. (2018). Role of pharmacists in providing parenteral nutrition support: Current insights and future directions. *Integrated Pharmacy Research & Practice, 7*, 125-140.

Koenen, B., Benjamin, R., & Panciu, A. (2019). Navigating the challenges of home parenteral nutrition. *Nutrition in Clinical Practice, 34*(2), 204-209.

Köglmeier, J., De Koning, B., & Norsa, L. (2022). Editorial: Innovative therapies and novel challenges in pediatric intestinal failure. *Frontiers in Nutrition, 9*, 1050004.

Kum, L., Zeilinger, E. L., Vohla, D., Kitta, A., Brunevskaya, N., Adamidis, F., et al. (2023). Routine laboratory parameters to support decision on parenteral nutrition in palliative care. *Frontiers in Nutrition, 10*, 1173106.

Kumpf, V. J., Gray, B., Monczka, J., Zeraschi, S., & Klek, S. (2024). Parenteral nutrition at home/long-term parenteral nutrition. *American Journal of Health-System Pharmacy, 81*(Supplement 3), S112-S120. https://doi.org/10.1093/ajhp/zxad 297

Lafuente Cabrero, E., Terradas Robledo, R., Civit Cuñado, A., García Sardelli, D., Hidalgo López, C., Giro Formatger, D., et al. (2023). Risk factors of catheter-associated bloodstream infection: Systematic review and meta-analysis. *PLOS ONE, 18*(3), e0282290. https://doi.org/10.1371/journal.pone.0282290

Lee, W. S., Chew, K. S., Ng, R. T., Kasmi, K. E., & Sokol, R. J. (2020). Intestinal failure-associated liver disease (IFALD): Insights into pathogenesis and advances in management. *Hepatology International, 14*(3), 305-316. https://doi.org/10.1007/s12072-020-10086-9

Ley, D., Austin, K., Wilson, K. A., & Saha, S. (2023). Tutorial on adult enteral tube feeding: Indications, placement, removal, complications, and ethics. *JPEN Journal of Parenteral and Enteral Nutrition, 47* (5), 677-685. https://doi.org/10.1002/jpen.2590

Limketkai, B. N., Mauldin, K., Manitius, N., Jalilian, L., & Salonen, B. R. (2021). The age of artificial intelligence: Use of digital technology in clinical nutrition. *Current Surgery Reports, 9*(7), 20.

Lopez-Delgado, J. C., Grau-Carmona, T., Mor-Marco, E., Bordeje-Laguna, M. L., Portugal-Rodriguez, E., Lorencio-Cardenas, C., et al. (2023). Parenteral nutrition: Current use, complications, and nutrition delivery in critically ill patients. *Nutrients, 15*(21). https://doi.org/10.3390/nu15214126

Luo, H., Duan, S. R., & Wang, H. (2022). Application protocol of standardized neonatal parenteral nutrition formulations. *Sichuan Da Xue Xue Bao Yi Xue Ban = Journal of Sichuan University Medical Science Edition, 53*(5), 941-944.

Malone, A., & Mogensen, K. M. (2022). Key approaches to diagnosing malnutrition in adults. *Nutrition in Clinical Practice, 37*(1), 23-34.

McGrath, K. H. (2019). Parenteral nutrition use in children with cancer. *Pediatric Blood & Cancer, 66*(12), e28000. https://doi.org/10.1002/pbc.28000

Mihatsch, W., Jiménez Varas, M., Diehl, L. L., Carnielli, V., Schuler, R., Gebauer, C., et al. (2023). Systematic review on individualized versus standardized parenteral nutrition in preterm infants. *Nutrients, 15*(5).

Monczka, J., Ayers, P., Berger, M. M., & Wischmeyer, P. E. (2024). Safety and quality of parenteral nutrition: Areas for improvement and future perspectives. *American Journal of Health-System Pharmacy, 81*(Supplement 3), S121-S136. https://doi.org/10.1093/ajhp/zxad 296

Mulazzani, G. E. G., Corti, F., Della Valle, S., & Di Bartolomeo, M. (2021). Nutritional support indications in gastroesophageal
cancer patients: From perioperative to
palliative systemic therapy. A
comprehensive review of the last decade.
*Nutrients*, **13**(8). https://doi.org/10.3390/
nu13082616

Mundi, M. S., Mohamed Elfadil, O., Hurt, R. T., Bonnes, S., & Salonen, B. R. (2023). Management of long-term home parenteral nutrition: Historical perspective, common complications, and patient education and training. *JPEN Journal of Parenteral and Enteral Nutrition, 47*(Suppl 1), S24-S34.

Murphy, J. L. (2022). Prevention, identification, and management of malnutrition in older people in the community. *Nursing Standard* (Royal College of Nursing), **37**(8), 75-81. https://doi.org/10.7748/ns.2022.e11655

Mutalib, M., Evans, V., Hughes, A., & Hill, S. (2015). Aseptic non-touch technique and catheter-related bloodstream infection in children receiving parenteral nutrition at home. *United European Gastroenterology Journal*, **3**(4), 393-398.

Parrish, C. R., & DiBaise, J. K. (2017). Managing the adult patient with short bowel syndrome. *Gastroenterology & Hepatology, 13*(10), 600-608.

Pavlidou, E., Papadopoulou, S. K., Seroglou, K., & Giaginis, C. (2023). Revised Harris-Benedict equation: New human resting metabolic rate equation. *Metabolites, 13*(2).

Pradelli, L., Klek, S., Mayer, K., Omar Alsaleh, A. J., Rosenthal, M. D., Heller, A. R., et al. (2021). Cost-effectiveness of parenteral nutrition containing ω-3 fatty acids in hospitalized adult patients from 5 European countries and the US. *JPEN Journal of Parenteral and Enteral Nutrition, 45*(5), 999-1008.

Pybus, R., & Puntis, J. W. (2021). Parenteral nutrition. *Archives of Disease in Childhood*,

106(9), 921-922.
https://doi.org/10.1136/archdischild-2021-321741

Rothkopf, M., Pant, M., Brown, R., Haselhorst, J., Gagliardotto, F., Tallman, A., et al. (2022). Impact of a multidisciplinary nutritional support team on quality improvement for patients receiving home parenteral nutrition. *BMJ Nutrition, Prevention & Health*, **5**(2), 286-296.

Rougier, L., Preiser, J. C., Fader, M., Verbrugge, A. M., Paquot, N., Ledoux, D., et al. (2021). Nutrition during critical care: An audit on actual energy and protein intakes. *JPEN Journal of Parenteral and Enteral Nutrition, 45*(5), 951-960.

Smith, A. E., Shah, M., & Badireddy, M. (2024). Failure to thrive. In *StatPearls* [Internet]. StatPearls Publishing.

Retrieved from https://www.statpearls.com

Uthaya, S. (2021). Better preterm parenteral nutrition practice. *Early Human Development, 162*, 1054-1068.

Wang, Y. S., Shen, W., Yang, Q., Lin, R., Tang, L. X., Bai, R. M., et al. (2023). Analysis of risk factors for parenteral nutrition-associated cholestasis in preterm infants: A multicenter observational study. *BMC Pediatrics*, **23**(1), 250.

https://doi.org/10.1186/s12887-023-04204-2

Winkler, M., & Tappenden, K. (2023). Epidemiology, survival, costs, and quality of life in adults with short bowel syndrome. *Nutrition in Clinical Practice*, **38**(Suppl 1), S17-S26.

Zaccone, V., Santoro, L., Guerrieri, E., Diblasi, I., Roncarati, I., Viticchi, G., et al. (2023). Prevention and treatment of catheter-related venous thrombosis in long-term parenteral nutrition: A SINuC position statement. *Frontiers in Nutrition, 10*, 1106-327.

**Disclaimer/Publisher's Note:** The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of the publisher and/or the editor(s). This publisher and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© Copyright (2024); Author(s). The licensee is the journal publisher. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Peer-review history:
The peer review history for this paper can be accessed here:
https://www.sdiarticle5.com/review-history/127763